CME and the pharmaceutical industry: two worlds, three views, four steps
Open Access
- 20 July 2004
- journal article
- editorial
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 171 (2) , 149-150
- https://doi.org/10.1503/cmaj.1040361
Abstract
The choice should be fairly easy: course B, given its better format, more clearly defined objectives and apparent freedom from the influence of the pharmaceutical industry, easily trumps course A — at least in the mind of the ethical, self-directed, evidence-based physician.Keywords
This publication has 8 references indexed in Scilit:
- What's wrong with CME?CMAJ : Canadian Medical Association Journal, 2004
- PERSPECTIVE: A Proposal to Enhance the Disclosure of Potential Conflict of Interest for Continuing Medical Education EventsTeaching and Learning in Medicine, 2003
- Defending Professional IndependencePublished by American Medical Association (AMA) ,2003
- America's other drug problem: how the drug industry distorts medicine and politics.2002
- Physician–Industry Relations. Part 1: Individual PhysiciansAnnals of Internal Medicine, 2002
- Physician–Industry Relations. Part 2: Organizational IssuesAnnals of Internal Medicine, 2002
- Physicians and the Pharmaceutical IndustryJAMA, 2000
- Interactions between physicians and the pharmaceutical industry: what does the literature say?1993